Ishita Drugs & Industries Ltd.

View in App
71.57 -0.79 ▼-1.1%

24 April 2024, 04:01:00 PM
Volume: 423

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ishitadrugs.com
Market Cap 21.41 Cr.
Enterprise Value(EV) 18.64 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.16 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 33.14 Trailing Twelve Months Ending 2023-12
Industry PE 41.22 Trailing Twelve Months Ending 2023-12
Book Value / Share 32.23 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.22 Calculated using Price: 71.59
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.30 Cr. 2,990,300 Shares
FaceValue 10
About Ishita Drugs & Industries Ltd.
Ishita drugs & industries limited (IDIL), an Ishita Group company was incorporated in 1992, the company is listed on the local stock exchanges in India and has earned a reputation as a 'high quality manufacturer' in a very short time.

Ishita Drugs & Industries Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Ishita Drugs & Industries Ltd. Performance

View details >>
1 Day
-1.09%
1 Week
+0.92%
1 Month
+6.57%
3 Month
-2.69%
6 Month
+8.00%
1 Year
+45.08%
2 Year
+37.63%
5 Year
+282.93%
10 Year
+378.09%

Ishita Drugs & Industries Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 4.12 2.47 3.19 4.17 5.64 8.18 11.25 9.82 6.5
Return on Capital Employed (%) 5.98 4.02 4.79 7.26 8.17 10.79 14.39 13 8.9
Return on Assets (%) 3.26 1.81 2.37 3.46 4.54 6.12 8.82 7.85 5.1

Ishita Drugs & Industries Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5 6 6 6 6 7 8 9 9 10
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 1 3 1 1 2 3 1 3 2 3
Minority Int.
Equity & Liab. 7 8 7 7 8 10 9 11 11 13
Non Curr. Assets 1 1 1 1 2 1 1 1 1 1
Curr. Assets 6 7 6 6 7 8 8 10 10 12
Misc. Exp. not W/O
Total Assets 7 8 7 7 8 10 9 11 11 13

Ishita Drugs & Industries Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 7 7 6 7 9 15 14 14 12 13
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 7 7 6 7 9 15 14 14 12 14
Total Expenditure -7 -6 -6 -6 -9 -14 -13 -13 -11 -12
PBIDT 0 0 0 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 1 1 1 1 1
Adjusted EPS 1 0 1 1 1 2 3 3 2 2

Ishita Drugs & Industries Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 0 0 1 1 1 1 -1 3 -3
Cash Fr. Inv. 0 0 0 -1 -1 -1 -1 2 -1 1
Cash Fr. Finan. 0 0 1 -1 0 0 0 0 1
Net Change 0 0 1 -1 0 0 0 2 2 -1
Cash & Cash Eqvt 1 1 2 1 1 1 1 3 5 3

Ishita Drugs & Industries Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 49.31 49.32 49.32 49.32 49.38 49.38 49.38 49.38 49.42
Public 50.69 50.68 50.68 50.68 50.62 50.62 50.62 50.62 50.58
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Ishita Drugs & Industries Ltd. Announcements

View details >>
Mon, 22 Apr 2024
Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31St March 2024
We are enclosing the certificate received from Ms. Meenu Maheshwari Practicing Company Secretary pursuant to the Regulation 40(9) and 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the year ended 31st March 2024.
Thu, 11 Apr 2024
Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31St March 2024
Pursuant to the requirement of Regulation 7(2) & 7 (3) of SEBI(LODR) Regulations 2015 Please find enclosed herewith Compliance Certificate received from our RTA for the financial year ended 31st March 2024.
Tue, 09 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
We submit herewith the confirmation certificate received from M/s Bigshare Services Private Limited RTA as per Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st March 2024.

Ishita Drugs & Industries Ltd. Technical Scans

View details >>
Wed, 24 Apr 2024
Opening at High Opening at High
High Increase in 1 Month High Increase in 1 Month
High Increase in 1 Year High Increase in 1 Year
High Increase in 5 Years High Increase in 5 Years
William %R Bearish William %R Bearish

Ishita Drugs & Industries Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,625.15 1,485.75 +0.1%
Cipla Ltd. 112,938.41 1,398.20 +3.8%
Divi's Laboratories Ltd. 101,314.76 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. 99,276.89 5,950.80 0.0%
Mankind Pharma Ltd. 96,143.23 2,398.30 +0.2%
Zydus Lifesciences Ltd. 93,921.88 933.50 -2.7%
Torrent Pharmaceuticals Ltd. 90,872.60 2,686.45 +1.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.04 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-12 30.46 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-12 73.26 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 18.99 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.67 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.58 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.83 2,686.45 +1.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.72 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-12 4.36 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-12 7.77 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.69 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.82 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.98 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.71 2,686.45 +1.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,686.45 +1.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,686.45 +1.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,686.45 +1.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,686.45 +1.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,485.75 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,398.20 +3.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,813.80 +1.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,950.80 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.30 +0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 933.50 -2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,686.45 +1.9%

Ishita Drugs & Industries Ltd. FAQ's

What is Ishita Drugs & Inds. share price?
Can I buy Ishita Drugs & Inds. shares now?
What is the Market Cap of Ishita Drugs & Inds.?
What are the key metrics to analyse Ishita Drugs & Inds.?
What is the 52 Week High and Low of Ishita Drugs & Inds.?
What is the trend of Ishita Drugs & Inds. share price?